About
Accuitis develops therapeutic small molecule drugs that restore mitochondrial SIRT3 expression to protect and restore healthy cellular function in neurodegenerative diseases such as Alzheimer's, Parkinson's, and methamphetamine addiction.
Explore Accuitis's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.